What is the Digital Pathology Market Size?
The global digital pathology market size is accounted at USD 1.28 billion in 2025 and predicted to increase from USD 1.39 billion in 2026 to approximately USD 2.76billion by 2035, expanding at a CAGR of 7.99% from 2026 to 2035. The North America digital pathology market size reached USD 490 million in 2025. The growing prevalence of chronic disorders drives the market's growth.
Digital Pathology Market Key Takeaways
- The global digital pathology market was valued at USD 1.28billion in 2025.
- It is projected to reach USD 2.76billion by 2035.
- The digital pathology market is expected to grow at a CAGR of 7.99% from 2026 to 2035.
- North America dominated the digital pathology market with the largest market share of 41% in 2025.
- Asia Pacific is estimated to be the fastest-growing during the forecast period of 2026 to 2035.
- By product, the device segment has contributed more than 53% of market share in 2025.
- By product, the software segment is expected to be the fastest-growing during the forecast period.
- By type, the human pathology segment has held a major market share of 61% in 2025.
- By type, the veterinary pathology segment is anticipated to be the fastest-growing during the forecast period.
- By application, the academic research segment accounted for the largest market share of 47% in 2025.
- By application, the disease diagnosis segment is estimated to be the fastest-growing during the forecast period.
- By end-use, the hospitals segment has generated more than 38% of market share in 2025.
- By end-use, the diagnostic labs segment is anticipated to be the fastest-growing during the forecast period.
What is Digital Pathology?
The digital pathology market refers to the process of converting glass transparencies containing tissue samples into digital images for analysis, dissemination, and storage. Digital pathology is a sub-field of pathology that focuses on data management based on information generated from digitized specimen slides. By using computer-based technology, digital pathology uses virtual microscopy .
The benefits of digital pathology include the potential for AI-based disease screening, reduced workload or fatigue for pathologists, improved patient outcomes like faster and higher quality results, standardization in pathology education, and transparent and consistent evaluation. Teleconsultations help pathologists to collaborate, engage, and evaluate remotely and rapidly. These factors help to the growth of the market.
How is AI contributing to the Digital Pathology Industry?
Digital pathology is enhanced through artificial intelligence, which automates the analysis of slides and assists the pathologist in the complicated diagnostic assessment. Digital images are used to identify tumors, measure biomarkers, and classify tissue patterns through machine learning models. AI points out suspicious areas to be reviewed, enhancing the efficiency of the workflow and diagnostic values.
Digital Pathology Market Growth Factors
- The benefits of digital pathology include the potential for AI-based disease screening, reduced workload or fatigue for pathologists, and improved patient outcomes like higher and faster quality results which helps to the growth of the market.
- It also includes remote access to expertise, standardization in pathology education, and transparent and consistent evaluation.
- Teleconsultations help pathologists to collaborate, evaluate, and engage remotely and rapidly, which helps the growth of the market.
- The applications of digital pathology include disease diagnosis, academic research, and drug discovery and development, which help the growth of the digital pathology market.
Digital Pathology Market Scope
| Report Coverage | Details |
| Market Size by 2035 | USD 2.76Billion |
| Market Size in 2025 | USD 1.28 Billion |
| Market Size in 2026 | USD 1.39 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 7.99% |
| Largest Market | North America |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product, Type, Application, End-use, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Market Dynamics
Driver
Rising digital solutions adoption
The rising adoption of digital solutions helps the growth of the market. Digital pathology solution benefits include access to advanced tools that allow for workplace flexibility, improved visualization capabilities, improved distribution that enables rapid and remote collaboration and engagement, reduced risk of slide breakage at the time of transport, faster and high-quality results, and consistent and transparent evaluation. These factors help the growth of the digital pathology market.
Restraint
High cost and lack of standard guidelines for digital pathology
High costs linked with the integration and implementation of software or hardware can hamper the growth of the market. The lack of standard guidelines for digital pathology may impact products' overall quality, employees' safety and health, the company's reputation, company's environmental footprint, company's capacity, and ability to meet customer demands. Disadvantages of digital pathology also include the transformation of the profession automation, working extensive screen times, regulatory requirements, best practices for safe implementation, and high investments in IT infrastructure and services. These factors can restrict the growth of the digital pathology market.
Opportunity
Future Projections
To transform the field of pathology as how teleradiology revolutionized the medical imaging industry , digital pathology has potential. Digital pathology technology helps to improve the digital diagnosis process. It makes it easy to give opinions on challenging cases. Image sharing with other pathologists enhances the accuracy of diagnoses.
The advantages of digital pathology include primary diagnosis of disease, easier modification of treatments for each patient, maximized patient outcomes by data analysis, it helps to give pathologists access to different patients' samples, it also helps to provide a complete view of patient's health and care, and also eliminating barriers related to location. When there are new discoveries, digital pathology allows colleagues to work together. These factors help the growth of the digital pathology market.
Segment Insights
Product Insights
The device segment dominated the market in 2025. The digital pathology device segment includes scanners and slide management systems. The benefits of scanners include ergonomics improvement, growth opportunities, faster turnaround time, better views, improved distribution, improved efficiency, and reduced errors, helping the market's growth. The benefits of slide management systems include providing a dashboard view of annotations and data, allowing for team annotation of slides, the ability to measure the number of AOI, and giving multiple angles and live zoomed views. These factors help to the growth of the device segment and contribute to the growth of the digital pathology market.
The software segment is expected to be the fastest-growing during the forecast period. The benefits of digital pathology software include allowing pathologists to collaborate, engage, and evaluate remotely and rapidly with consistency and transparency, which helps improve productivity and efficiency. Digital pathology software helps improve personalized medicines , translational research, and computer-aided diagnosis. These factors help the growth of the software segment and contribute to the growth of the digital pathology market.
- In March 2023, a software company that develops AI-based pathology software, Aiosyn, was launched to assist digital pathology labs across pharma, research, and diagnostics to improve their quality control process.
Type Insights
The human pathology segment dominated the digital pathology market in 2025. In the field of human pathology, digital pathology plays an important role. Digital pathology helps to improve lab productivity and eliminates the time required for disease diagnosis. The increase in the prevalence of chronic diseases in humans leads to an increase in the growth of the market. The benefits of digital pathology include improved diagnostics accuracy due to multiplane examination and high resolution. These factors help the growth of the human pathology segment and contribute to the growth of the market.
The veterinary pathology segment is anticipated to be the fastest-growing during the forecast period. The digital pathology plays an important role in veterinary pathology. Pathologists can use AI algorithms and digital imaging to analyze samples from distant locations, expanding access to improve patient care and veterinary pathology services. Digital pathology of veterinary pathology includes interpretation, sharing, management, and acquisition of pathology information by using high-resolution digital images. These factors help to the growth of the veterinary pathology segment and contribute to the growth of the digital pathology market.
Application Insights
The academic research segment dominated the market in 2025. Digital pathology plays an important role in academic research. The benefits include quantitative pathologic assessments, improved learning opportunities, active learning, improved accessibility, resource consumption, reduced costs, reduced resource consumption, and streamlined collaboration can help the growth of the segment. Digital pathology offers improved access, efficiency, and consistency to pathology data, which is beneficial for academic research. These factors help the growth of the academic research segment and contribute to the growth of the digital pathology market.
The disease diagnosis segment is estimated to be the fastest-growing during the forecast period. Digital pathology plays a significant role in the disease diagnosis. It offers many benefits for disease diagnosis, which include faster turnaround time, improved collaboration, remote diagnosis, data preservation, accuracy, and consistency. The benefits of disease diagnosis include primary diagnosis of disease, making easier adoption of treatments for each patient, maximizing patient outcomes by data analysis, eliminating barriers related to location, and helping to give pathologists access to different patient samples. These factors help to the growth of the disease diagnosis segment and contribute to the growth of the digital pathology market.
End-use Insights
The hospital segment dominated the digital pathology market in 2025. Digital pathology offers many benefits to hospitals, which include several areas of expertise under one roof, cost savings, greater long-term insights, increased patient safety, increased accuracy and reliability, continuous learning, enhanced patient accessibility, enhanced precision, streamlined workflows, potential for AI-based disease screening, reduced workload/fatigue for pathologists, improved patient outcomes, remote access to expertise, standardization in pathology education, and teleconsultation. These factors help to the growth of the hospital segment and contribute to the growth of the market.
The diagnostic labs segment is anticipated to be the fastest-growing during the forecast period. Digital pathology offers many benefits for diagnostics labs, including precision of diagnosis, effective processes, wide-scale collaboration, faster diagnostics, cost savings, etc. The benefits also include ergonomic equipment, growth opportunities, faster turnaround time, increased flexibility, better views, improved efficiency, and reduced errors. These factors help to the growth of the diagnostic labs and contribute to the growth of the digital pathology market.
Regional Insights
What is the U.S. Digital Pathology Market Size?
The U.S. digital pathology market size was exhibited at USD 390 million in 2025 and is projected to be worth around USD 870 million by 2035, poised to grow at a CAGR of 8.35% from 2026 to 2035.
North America dominated the digital pathology market in 2025. Rising government initiatives for the development of advanced pathology technologies, increasing adoption of digital imaging, and R&D investments help the growth of the market in the North American region.
- In March 2023, in North America, the leading end-to-end digital pathology solution provider, OptraSCAN, launched the ‘OnDemand Digital Pathology' solutions to meet the solutions for complete digital transformation of pathology laboratories.
- In July 2024, in North America, a global leader in healthcare imaging management solutions, AGFA Healthcare, announced that an integrated solution for digital transformation in pathology was powered by Corista DP3. This helps to reduce complexity, enhance clinical collaboration, and allow efficiencies in the pathology workflow.
U.S. Digital Pathology Market Trends
The market of digital pathology in the U.S. grows with the high level of integration of artificial intelligence into the diagnostic processes. The adoption of artificial intelligence-based pathology software is promoted by regulatory clearances. Telepathology systems that provide remote consultation, collaboration, and workload management are increasingly being used by healthcare providers to operate across hospital networks and specialized oncology laboratories.
Asia Pacific is estimated to be the fastest-growing during the forecast period of 2026 to 2035. Increasing digital imaging penetration, increasing investment, and rapid digitalization in the medical field can help the growth of the digital pathology market in the Asia Pacific region.
- In July 2024, a leader in digital pathology solutions, Indica Labs, announced its expansion across the Asia Pacific region.
- In July 2024, in India, the Micalys digital microscopy platform was launched by a medical device company, Medprime Technologies, to revolutionize digital pathology.
China Digital Pathology Market Trends
China's digital pathology market is the fast-growing market with the increasing number of large-scale healthcare digitization projects and the programs of hospital modernization. The general spread of digital slide scanners and cloud storage platforms is supported by the public healthcare infrastructure. Local technology startups build AI-based diagnostic tools that are trained using local clinical data to aid quicker cancer diagnosis and digital cytology examination.
Digital Pathology Market Companies
- Bionovation Biotech Inc.: Innovates ultra-fast whole slide scanners with high resolution imaging, remote consultation solutions, and adjustable artificial intelligence training solutions.
- Morphle Labs Inc.: Offers robotic microscopes and cloud software, which is intended to serve automated cancer diagnostics, high throughput scanning, and distant pathology association.
- SigTuple Technologies Private Limited: Presents AI-enabled robotic microscopy systems that digitize blood and urine smears and allow automated laboratory examination and better diagnosis.
Other Major Key Players
- IBEX (IBEX MEDICAL ANALYTICS)
- aetherAI
- West Medica Produktions- und Handles- GmbH (West Medica)
- HANGZHOU ZHIVEI INFORMATION TECHNOLOGY CO.LTD. (MORPHOGO)
- CellaVision
- ContextVision AB
- Huron Technologies International Inc.
- Visiopharm A/S
- Epredia (3DISTECH Ltd.)
- Inspirata, Inc.
- Mikroscan Technologies, Inc.
- F. Hoffmann-La Roche Ltd
- Olympus Corporation
- Koninklijke Philips N.V.
- Hamamatsu Photonics, Inc.
- Leica Biosystems Nussloch GmbH (Danaher)
Recent Developments
- In March 2026, Philips introduced the IntelliSite Pathology Solution on HealthSuite, a cloud-based platform using AWS. It facilitates secure storage and analysis of high-resolution pathology images, enabling remote collaboration for pathologists. The solution aims to enhance workflow efficiency and promote digital pathology's clinical use. ( https://clpmag.com/diagnostic-technologies )
- In December 2026, Leica Biosystems, a Danaher company, announces the launch of the Aperio GT 180 DX scanner, Aperio CS5 DX scanner, and Aperio iQC DX software, advancing digital pathology. These innovations debuted at the Digital Pathology and AI Congress in London, enhancing the Aperio Digital Pathology clinical portfolio showcased at booth . ( https://www.prnewswire.com )
- In November 2023, PharmaNest Inc., Alimentiv Inc., and AcelaBio Inc. collaborated to revolutionize precision medicine and AI-based digital pathology for MASH (metabolic dysfunction associated steatohepatitis)/NASH (nonalcoholic steatohepatitis) clinical trials.
- In April 2024, Sectra and Leica Biosystems, Imaging Inc. received clearance from the Food and Drug Administration (FDA) for the use of DICOM images in digital pathology for pathology diagnostics.
- In July 2024, Philips IntelliSite Pathology Solution received 510 (K) clearance to strengthen Philips's leadership in digital pathology. This helps to improve diagnostics efficiency and accuracy by integrating pathology into broader IT infrastructure and precision diagnostics systems.
Segments Covered in the Report
By Product
- Software
- Device
- Scanners
- Slide Management System
- Storage System
By Type
- Human Pathology
- Veterinary Pathology
By Application
- Drug Discovery and Development
- Academic Research
- Disease Diagnosis
- Cancer Cell Detection
- Others
By End-use
- Hospitals
- Biotech & Pharma Companies
- Diagnostic Labs
- Academic & Research Institutes
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Tags
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Free Sample
Table Of Content
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting